Cees van Kooten, PhD
Cees van Kooten, PhD
Professor in Experimental Nephrology & Transplant Immunology, dept of Nephrology, LUMC, Leiden
Verified email at
Cited by
Cited by
CD40‐CD40 ligand
C van Kooten, J Banchereau
Journal of leukocyte biology 67 (1), 2-17, 2000
Activation of human dendritic cells through CD40 cross-linking.
C Caux, C Massacrier, B Vanbervliet, B Dubois, C Van Kooten, I Durand, ...
The Journal of experimental medicine 180 (4), 1263-1272, 1994
The CD40 antigen and its ligand
J Banchereau, F Bazan, D Blanchard, F Briè, JP Galizzi, C Van Kooten, ...
Annual review of immunology 12 (1), 881-926, 1994
Generation of memory B cells and plasma cells in vitro
C Arpin, J Dechanet, C Van Kooten, P Merville, G Grouard, F Briere, ...
Science 268 (5211), 720-722, 1995
Functions of CD40 on B cells, dendritic cells and other cells
C van Kooten, J Banchereau
Current opinion in immunology 9 (3), 330-337, 1997
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease
A Roos, MP Rastaldi, N Calvaresi, BD Oortwijn, N Schlagwein, ...
Journal of the American Society of Nephrology 17 (6), 1724-1734, 2006
Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
P Garrone, EM Neidhardt, E Garcia, L Galibert, C Van Kooten, ...
The Journal of experimental medicine 182 (5), 1265-1273, 1995
Production of complement components by cells of the immune system
R Lubbers, MF Van Essen, C Van Kooten, LA Trouw
Clinical & Experimental Immunology 188 (2), 183-194, 2017
TGF-β1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2)
F Strutz, M Zeisberg, A Renziehausen, B Raschke, V Becker, ...
Kidney international 59 (2), 579-592, 2001
CD40-CD40 ligand: a multifunctional receptor-ligand pair
C Van Kooten, J Banchereau
Advances in immunology 61, 1-77, 1996
Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes
B Dubois, B Vanbervliet, J Fayette, C Massacrier, CV Kooten, F Brière, ...
The Journal of experimental medicine 185 (5), 941-952, 1997
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study
MEJ Reinders, JW de Fijter, H Roelofs, IM Bajema, DK de Vries, ...
Stem cells translational medicine 2 (2), 107-111, 2013
A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation
D Graf, S Müller, U Korthäuer, C van Kooten, C Weise, RA Kroczek
European journal of immunology 25 (6), 1749-1754, 1995
F Fossiez, J Banchereau, R Murray, C Van Kooten, P Garrone, ...
International reviews of immunology 16 (5-6), 541-551, 1998
Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection.
C Van Kooten, JG Boonstra, ME Paape, F Fossiez, J Banchereau, ...
Journal of the American Society of Nephrology 9 (8), 1526-1534, 1998
The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells
AM Woltman, JW Fijter, SWA Kamerling, L C. Paul, MR Daha, C Kooten
European journal of immunology 30 (7), 1807-1812, 2000
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes
LA Trouw, TWL Groeneveld, MA Seelen, JMGJ Duijs, IM Bajema, FA Prins, ...
The Journal of clinical investigation 114 (5), 679-688, 2004
Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells
AJ Nauta, G Castellano, W Xu, AM Woltman, MC Borrias, MR Daha, ...
The Journal of Immunology 173 (5), 3044-3050, 2004
Recognition and clearance of apoptotic cells: a role for complement and pentraxins
AJ Nauta, MR Daha, C van Kooten, A Roos
Trends in immunology 24 (3), 148-154, 2003
Chronic renal allograft rejection: pathophysiologic considerations
SA Joosten, YWJ Sijpkens, C Van Kooten, LC Paul
Kidney international 68 (1), 1-13, 2005
The system can't perform the operation now. Try again later.
Articles 1–20